AlphaCrest Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

AlphaCrest Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,390	Closed	-$1.01M	–	1209
2022 Q3	$1.01M	Sell	14,390 -99	-0.7%	-$6.83K	0.06%	602
2022 Q2	$821K	Buy	14,489 +11,294	+353%	+$619K	0.04%	749
2022 Q1	$200K	Buy	+3,195	New	+$172K	0.01%	1212
2021 Q4	–	Sell	-9,333	Closed	-$607K	–	1458
2021 Q3	$607K	Buy	+9,333	New	+$637K	0.03%	836
2021 Q1	–	Sell	-12,700	Closed	-$634K	–	1335
2020 Q4	$634K	Buy	12,700 +2,700	+27%	+$127K	0.05%	520
2020 Q3	$510K	Buy	+10,000	New	+$417K	0.06%	573

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

AlphaCrest Capital Management's AXNX Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 14,390 shares — an estimated $1.01M sold.

AlphaCrest Capital Management first reported a position in AXNX in Q3 2020 and held it in 6 quarters. The position peaked at $1.01M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

AlphaCrest Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 14,390 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $1.01M.
AlphaCrest Capital Management first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
AlphaCrest Capital Management's Axonics, Inc. Common Stock position peaked at $1.01M in Q3 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.